Human Biomonitoring in Health Risk Assessment of Emerging Chemicals

A special issue of Toxics (ISSN 2305-6304). This special issue belongs to the section "Human Toxicology and Epidemiology".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 505

Special Issue Editors


E-Mail Website
Guest Editor
School of Public Health, Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou 310053, China
Interests: e-waste; disposable plastics; fast food; takeaway food; health risk; heavy metals; emerging contaminants; microbiota; metabolomics

E-Mail Website
Guest Editor
School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou 510275, China
Interests: environmental contaminants; human exposure; organic pollutants; risk assessment; early life

Special Issue Information

Dear Colleagues,

The Special Issue "Human Biomonitoring in Health Risk Assessment of Emerging Chemicals" is a collection of research articles that explore the role of human biomonitoring in assessing the health risks associated with emerging chemicals. Human biomonitoring is a scientific approach that involves the measurement of chemicals or their metabolites in biological samples (such as blood, urine, hair, or tissues) collected from humans. This technique is used to assess exposure to various chemicals, including emerging contaminants, and to evaluate potential health risks associated with these exposures. This Special Issue would provide a valuable platform for researchers, policymakers, and stakeholders to share their latest findings and insights on the role of human biomonitoring in assessing health risks associated with emerging chemicals. By focusing on key areas such as emerging contaminants, biomarker development, population studies, health outcomes, and regulatory implications, this Special Issue could contribute to advancing our understanding of the potential health risks posed by these chemicals and inform efforts to protect public health.

Dr. Xiang Zeng
Dr. Shaoyou Lu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomonitoring
  • health risk
  • emerging chemicals
  • PFAS
  • PAEs
  • BPs
  • microplastics
  • 6PPD
  • dechlorane plus
  • heavy metals

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 19754 KiB  
Article
Protective Effects of Polygonatum sibiricum Polysaccharides Against Type 2 Diabetic Mice Induced by High-Fat Diet and Low-Dose Streptozotocin
by Qingxiangzi Li, Jufen Cheng, Yangyang Sun, Liang He and Rui Li
Toxics 2025, 13(4), 255; https://doi.org/10.3390/toxics13040255 - 28 Mar 2025
Viewed by 254
Abstract
Polysaccharides possessing hypoglycemic effects have shown promising results in treating diabetes. Polygonatum sibiricum polysaccharide (PSP) is one of the most active ingredients in the Chinese medicine P. sibiricum Redoute with many biological activities. However, its efficacy in alleviating type 2 diabetes mellitus (T2DM) [...] Read more.
Polysaccharides possessing hypoglycemic effects have shown promising results in treating diabetes. Polygonatum sibiricum polysaccharide (PSP) is one of the most active ingredients in the Chinese medicine P. sibiricum Redoute with many biological activities. However, its efficacy in alleviating type 2 diabetes mellitus (T2DM) remains unexplored. Our aim is to evaluate the protective effect of PSP against T2DM by measuring body weight and serum biochemical indicators, examining the histopathological images of pancreatic and liver tissues, detecting fecal short-chain fatty acid (SCFA) content, and analyzing the intestinal flora diversity and the microbiota structure in T2DM mice. The findings indicated that PSP treatment in T2DM mice could obviously decrease the fasting blood glucose and fasting insulin levels, ameliorate glucose tolerance, insulin resistance, lipid, and inflammatory factor levels, attenuate pancreatic and liver damage, and increase the fecal SCFA content. In addition, PSP could modulate the composition of gut microbiota in T2DM mice, resulting in the relative abundance of Firmicutes decreasing and that of Bacteroidetes increasing, along with the abundance of beneficial flora significantly increasing, especially SCFA-producing bacteria. The findings indicate that PSP administration protected against diabetes by controlling disordered glucolipid metabolism and modulating the gut microbiota, which provides a valuable strategy for the utilization of PSP to treat T2DM. Full article
(This article belongs to the Special Issue Human Biomonitoring in Health Risk Assessment of Emerging Chemicals)
Show Figures

Figure 1

Back to TopTop